Symbols

HYPR

Hyperfine·NASDAQ

--(--)

HYPR fundamentals

HYPR Q4 2025 Earnings

Hyperfine (HYPR) released its earnings on Mar 18, 2026: revenue was 5.29M (YoY +128.05%), beat estimates; EPS was -0.06 (YoY +57.14%), beat estimates.

Revenue / YoY

5.29M

+128.05%

EPS / YoY

-0.06

+57.14%

Report date

Mar 18, 2026

HYPR Earnings Call Summary for Q4,2025

Revenue Surge: Q4 2025 revenue up 128% YoY to $5.3 million, with 16 next-gen Swoop systems sold. Full-year 2025 revenue grew 5% to $13.6 million.
Gross Margin Expansion: Q4 gross margin 50.9% (vs. 38.6% prior), full-year 49.8% (+410bps YoY).
Clinical Validation: 98% MRI concordance in neurology offices, 1-1.5 year ROI for hospitals, and 4x patient preference for portable MRI.
2026 Outlook: $20-22 million revenue (+55% midpoint), 50-55% gross margin, $26-28 million cash burn.
Key Drivers: Multi-unit IDN deals, India expansion, and segmented pricing strategy ($590k MSRP for hospitals, $550k for offices).

Earnings

EPS

Revenue

Revenue & Expenses

HYPR has released its 2025 Q4 earnings report, with revenue of 5.29M, reflecting a YoY change of 128.05%, and net profit of -5.91M, showing a YoY change of 43.10%. The Sankey diagram below clearly presents HYPR's revenue sources and cost distribution.

Key Indicators

Hyperfine (HYPR) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Hyperfine (HYPR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Hyperfine (HYPR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Hyperfine (HYPR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown